|
| |
dainippon pharmaceutical Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioSpace - Dainippon Pharmaceutical News, Search Jobs, Events
19 Oct 2005 ... Kissei Pharmaceutical Co., Ltd., Dainippon Pharmaceutical Conclude Licensing Agreement For KGA-2727 Diabetes Drug Candidate 10/19/2005 ...
http://www.biospace.com/company_profile.aspx?CompanyID=2015...
|
AD-5423 (Dainippon Pharmaceutical Co Ltd). [IDrugs. 1998] - PubMed ...
AD-5423 (Dainippon Pharmaceutical Co Ltd). Heading CE. 11 Kingsend, Ruislip, Middlesex, HA4 7DD, UK. AD-5423, a D(2)/5-HT(2) antagonist, is in phase II ...
http://www.ncbi.nlm.nih.gov/pubmed/18465651...
|
BioPortfolio - DAINIPPON usa
BioPortfolio - Dainippon Pharmaceuticals USA Corporation Dainippon Pharmaceuticals USA ... BioPortfolio - Dainippon Pharmaceutical USA Corporation
...
http://www.bioportfolio.com/search/DAINIPPON_usa.html...
|
Dainippon Sumitomo Pharma Co., Ltd. And Eisai Company, Ltd. Sign ...
17 Apr 2006 ... Under this agreement, Dainippon Sumitomo Pharma will grant rights of development , manufacture and marketing of "Gasmotin" in 10 Asian ...
http://www.biospace.com/news_story.aspx?NewsEntityId=15482...
|
TAK-677 Dainippon/Takeda Stephan Francke
393513 Annual Report 2000: Dainippon. Dainippon Pharmaceutical Co Ltd .... Dainippon Pharmaceutical Co Ltd ANNUAL REPORT 2001 March 31.
http://www.biomedcentral.com/content/pdf/cd-470186.pdf...
|
Search Results | Takeda Pharmaceutical Company Limited
Discontinuation of Development of Anti-Diabetic Agent AJ-9677/TAK-677 September 25, 2003; OSAKA, JAPAN, September 25, 2003 --- Dainippon Pharmaceutical Co., ...
http://www.takeda.com/search/?q=td...
|
BioSpace - Dainippon Sumitomo Pharma Co., Ltd. News, Search Jobs ...
Dainippon Sumitomo Pharma Co., Ltd. Receives Approval For Orally Disintegrating Formulation Of Amlodin, Hypertension/Angina Pectoris Treatment 3/21/2006 ...
http://www.biospace.com/company_profile.aspx?CompanyId=91962...
|
Discontinuation of Development of Anti-Diabetic Agent AJ-9677/TAK ...
OSAKA, JAPAN, September 25, 2003 --- Dainippon Pharmaceutical Co., Ltd. (" Dainippon") and Takeda Chemical Industries, Ltd. ("Takeda") today announced that
...
http://www.takeda.com/press/article_785.html...
|
BioSpace - Sumitomo Pharmaceuticals Co. Ltd. News, Search Jobs, Events
19 Oct 2005 ... Dainippon Pharmaceutical , Sumitomo Pharmaceuticals Co. Ltd. Unveil Name, Corporate Missions And Logo For New Merged Company 10/19/2005 ...
http://www.biospace.com/company_profile.aspx?CompanyId=2731...
|
Elan: Elan Announces Strategic Transaction; Eisai to Purchase ...
Zonegran was developed in Japan and in the United States by Dainippon Pharmaceutical Co., Ltd. of Osaka, Japan. Elan licensed the sales and marketing
rights ...
http://www.elan.com/News/2004/20040330_2.asp...
|
|
